FDC Ltd, founded in 1936 as one of India’s leading integrated pharmaceutical companies and a pioneer in Oral Rehydration Salts (ORS) with brands like Electral, Zifi, and Zocon, reported significantly lower profits amid revenue contraction for Q2FY26.
Financial Highlights:
- Revenues declined 7.98% year-on-year to ₹473 crore from ₹514 crore.
- Total expenses fell marginally 0.87% to ₹455 crore from ₹459 crore.
- Consolidated net profit plunged 61.11% to ₹28 crore from ₹72 crore.
- Earnings per share dropped 60.63% to ₹1.74 from ₹4.42.
Seasonal weakness, pricing pressures, and operational challenges led to margin collapse with operating margins at 7.15% (down 1,450 bps QoQ).
Outlook:
FDC Ltd focuses on branded formulations recovery, US market expansion (ophthalmic approvals), and cost discipline to stabilize earnings trajectory.
Explore the company’s past earnings and latest concall transcripts, click here to visit the AlphaStreet India News Channel.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,